+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Statin-induced necrotizing myositis - a discrete autoimmune entity within the "statin-induced myopathy spectrum"



Statin-induced necrotizing myositis - a discrete autoimmune entity within the "statin-induced myopathy spectrum"



Autoimmunity Reviews 12(12): 1177-1181



Statin-induced necrotizing myositis is increasingly being recognised as part of the "statin-induced myopathy spectrum". As in other immune-mediated necrotizing myopathies, statin-induced myositis is characterised by proximal muscle weakness with marked serum creatinine kinase elevations and histological evidence of myonecrosis, with little or no inflammatory cell infiltration. Unlike other necrotizing myopathies, statin-induced myopathy is associated with the presence of autoantibodies directed against 3-hydroxy-3-methylglutaryl- coenzyme A reductase (the enzyme target of statin therapies), and with Human Leukocyte Antigen-DRB1*11. This article summarises the clinical presentation, investigations and management of this rare, but serious complication of statin therapy.

(PDF emailed within 0-6 h: $19.90)

Accession: 055911597

Download citation: RISBibTeXText

PMID: 23851103

DOI: 10.1016/j.autrev.2013.07.001


Related references

Statin-induced necrotizing myositis a a discrete autoimmune entity within the a ostatin-induced myopathy spectrum. 2013

Statin induced necrotizing autoimmune myopathy. Journal of the Neurological Sciences 351(1-2): 13-17, 2016

When Should a Patient with Statin-Induced Myopathy Be Re-challenged? A Case of Necrotizing Autoimmune Myopathy. Case Reports in Rheumatology 2018: 1215653, 2018

An Unusual Case of Statin-Induced Myopathy: Anti-HMGCoA Necrotizing Autoimmune Myopathy. Journal of General Internal Medicine 30(12): 1879-1883, 2016

Statin-induced necrotizing autoimmune myopathy: importance of early recognition. British Journal of Hospital Medicine 78(6): 352-353, 2017

Necrotizing Autoimmune myopathy: A case report on statin induced rhabdomyolysis requiring immunosuppressive therapy. Drug Discoveries and Therapeutics 12(5): 315-317, 2018

Dermatomyositis-like syndrome revealing statin-induced necrotizing autoimmune myopathy with anti-HMGCR antibodies. Annales de Dermatologie et de Venereologie 2019, 2019

A Discrete Event Simulation Model to Assess the Economic Value of a Hypothetical Pharmacogenomics Test for Statin-Induced Myopathy in Patients Initiating a Statin in Secondary Cardiovascular Prevention. Molecular Diagnosis and Therapy 22(2): 241-254, 2018

Atorvastatin-induced necrotizing autoimmune myositis: An emerging dominant entity in patients with autoimmune myositis presenting with a pure polymyositis phenotype. Medicine 96(3): E5694, 2017

Statin-associated necrotizing autoimmune myopathy. Modern Rheumatology 24(5): 862-864, 2015

Statin-associated necrotizing autoimmune myopathy. Modern Rheumatology, 2013

Autoimmune necrotizing myopathy after statin discontinuation. Bmj Case Reports 12(5), 2019

Identifying statin-associated autoimmune necrotizing myopathy. Cleveland Clinic Journal of Medicine 81(12): 736-741, 2016

Rechallenging Statin Therapy in Veterans With Statin-Induced Myopathy Post Vitamin D Replenishment. Journal of Pharmacy Practice 30(5): 521-527, 2016

Statin induced myopathy and myalgia: time trend analysis and comparison of risk associated with statin class from 1991-2006. Plos One 3(6): E2522, 2008